These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 16707032

  • 21. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.
    Svensson TH.
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):320-9. PubMed ID: 10719159
    [Abstract] [Full Text] [Related]

  • 22. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.
    Hertel P, Nomikos GG, Schilström B, Arborelius L, Svensson TH.
    Neuropsychopharmacology; 1997 Jul; 17(1):44-55. PubMed ID: 9194049
    [Abstract] [Full Text] [Related]

  • 23. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T, Meltzer HY, Ichikawa J.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
    [Abstract] [Full Text] [Related]

  • 24. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
    Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH.
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
    [Abstract] [Full Text] [Related]

  • 25. Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine.
    Amargós-Bosch M, López-Gil X, Artigas F, Adell A.
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):565-73. PubMed ID: 16316487
    [Abstract] [Full Text] [Related]

  • 26. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
    Kalkman HO, Loetscher E.
    Eur J Pharmacol; 2003 Feb 21; 462(1-3):33-40. PubMed ID: 12591093
    [Abstract] [Full Text] [Related]

  • 27. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S, Reckless GE, Nobrega JN, Fletcher PJ, Kapur S.
    Neuropsychopharmacology; 2006 Sep 21; 31(9):1854-63. PubMed ID: 16319908
    [Abstract] [Full Text] [Related]

  • 28. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J, Li Z, Dai J, Meltzer HY.
    Brain Res; 2002 Nov 29; 956(2):349-57. PubMed ID: 12445705
    [Abstract] [Full Text] [Related]

  • 29. Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality.
    Svensson TH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct 29; 27(7):1145-58. PubMed ID: 14642973
    [Abstract] [Full Text] [Related]

  • 30. Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex.
    Devoto P, Flore G, Saba P, Scheggi S, Mulas G, Gambarana C, Spiga S, Gessa GL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar 02; 90():97-103. PubMed ID: 30472147
    [Abstract] [Full Text] [Related]

  • 31. Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat.
    Marcus MM, Nomikos GG, Malmerfelt A, Zachrisson O, Lindefors N, Svensson TH.
    Brain Res Mol Brain Res; 1997 May 02; 45(2):275-82. PubMed ID: 9149102
    [Abstract] [Full Text] [Related]

  • 32. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
    Volonté M, Monferini E, Cerutti M, Fodritto F, Borsini F.
    J Neurochem; 1997 Jul 02; 69(1):182-90. PubMed ID: 9202309
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.
    Natesan S, Reckless GE, Barlow KB, Nobrega JN, Kapur S.
    Neuropsychopharmacology; 2007 Jul 02; 32(7):1540-9. PubMed ID: 17164815
    [Abstract] [Full Text] [Related]

  • 34. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.
    Frånberg O, Wiker C, Marcus MM, Konradsson A, Jardemark K, Schilström B, Shahid M, Wong EH, Svensson TH.
    Psychopharmacology (Berl); 2008 Feb 02; 196(3):417-29. PubMed ID: 17940749
    [Abstract] [Full Text] [Related]

  • 35. Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).
    Morimoto T, Hashimoto K, Yasumatsu H, Tanaka H, Fujimura M, Kuriyama M, Kimura K, Takehara S, Yamagami K.
    Neuropsychopharmacology; 2002 Apr 02; 26(4):456-67. PubMed ID: 11927170
    [Abstract] [Full Text] [Related]

  • 36. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.
    Li XM, Perry KW, Wong DT, Bymaster FP.
    Psychopharmacology (Berl); 1998 Mar 02; 136(2):153-61. PubMed ID: 9551772
    [Abstract] [Full Text] [Related]

  • 37. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT, Veinbergs I, Dyssegaard A, Brunmark P, Tabatabaei A, Davis RE, Brann MR, Hacksell U, Bonhaus DW.
    J Pharmacol Exp Ther; 2007 Aug 02; 322(2):862-70. PubMed ID: 17519387
    [Abstract] [Full Text] [Related]

  • 38. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
    Björkholm C, Jardemark K, Marcus MM, Malmerfelt A, Nyberg S, Schilström B, Svensson TH.
    Eur Neuropsychopharmacol; 2013 Jul 02; 23(7):709-20. PubMed ID: 22732518
    [Abstract] [Full Text] [Related]

  • 39. Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
    Kleven MS, Assié MB, Cosi C, Barret-Grévoz C, Newman-Tancredi A.
    Psychopharmacology (Berl); 2005 Feb 02; 177(4):373-80. PubMed ID: 15448976
    [Abstract] [Full Text] [Related]

  • 40. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
    Jardemark KE, Liang X, Arvanov V, Wang RY.
    Neuroscience; 2000 Feb 02; 100(1):1-9. PubMed ID: 10996453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.